LOGIN
AAOS 2016: Liposomal bupivacaine versus interscalene nerve block in shoulder arthroplasty
March 2016
AAOS 2016: Liposomal bupivacaine versus interscalene nerve block in shoulder arthroplasty
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Liposomal Bupivacaine Versus Interscalene Nerve Block in Managing Pain After Shoulder Arthroplasty
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
80 patients undergoing either total shoulder arthroplasty (TSA) or reverse TSA were included in the study. The study was conducted in order to identify the optimal postoperative pain management regimen between locally infiltrated liposomal bupivacaine and an interscalene nerve block, thus patients were randomized to receive one of the above interventions. Findings showed no significant differences...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.